Blazma connects diagnostic orders, laboratories, devices, clinical systems, patients and physicians, turning fragmented diagnostic data into coordinated workflows, intelligent insights and measurable follow-up.
Delta Medical Laboratories reported measurable operational, financial and commercial improvements following its use of Blazma.
Orders are often created in one system, executed in another, reviewed elsewhere, and delivered without a connected follow-up process. The result is manual work, repeated testing, incomplete context, delayed referrals, and limited visibility into capacity and cost.
Clinical, laboratory, payer, device and operational data remain distributed across disconnected applications.
Important tasks, approvals and escalations can fall between organizations, sites and teams.
Leaders struggle to see true workload, quality, utilization, referral cost and service performance.
A verified result does not always translate into documented follow-up and measurable patient response.
Blazma is not a single-point tool. It creates one operating model across the work itself, the systems around it and the intelligence produced from it.
Orders, patients, specimens, analyzers, quality, referrals, billing and follow-up.
HIS, EHR, LIS, ERP, insurers, devices, logistics, patient channels and national platforms.
Routing, communications, exceptions, handoffs, alerts, approvals and back-office work.
Turnaround, capacity, staffing, inventory, referrals, cost per test, revenue and waste.
Unified diagnostic data, Smart Reports, AI-assisted insights and population intelligence.
Blazma can operate as a full laboratory information system, coordinate multiple existing systems, or extend selected workflows. The architecture is defined by the approved operating model, not by a requirement to replace every system.
Control the journey from electronic request and patient preparation through collection, processing, validation, critical communication and reporting.
Explore operations →Exchange governed data across systems and devices, monitor interfaces, automate handoffs, and route exceptions to accountable owners.
Explore interoperability →Connect operational activity to cost, capacity, inventory, referrals, revenue, service levels and customer performance.
Explore performance →Blazma unifies clinical, laboratory, quality, logistics, financial and operational data into decision-ready views. Approved AI can then support trend analysis, prioritization, Smart Reports and population-level insight under defined governance and human oversight.
Volumes, TAT, workload, capacity, exceptions, analyzer availability and service levels.
Cost per test, inventory consumption, referral cost, revenue and reconciliation.
Longitudinal trends, abnormal changes, risk prioritization and physician-reviewable insights.
Governed population indicators, demand patterns, capacity needs and early signals.
At Delta Medical Laboratories, Blazma was used as an end-to-end LIS and central application-ecosystem layer. Delta reported lower manual work, fewer process errors, stronger cost visibility, higher automation and commercial growth.
Customer impact report